Mylan reports total revenues of $3.74 billion for the nine months ended September 30, 2009

NewsGuard 100/100 Score

Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three and nine months ended September 30, 2009.

Financial Highlights

  • Adjusted diluted EPS of $0.32 and $0.97 for the three and nine months ended September 30, 2009, compared to $0.23 and $0.52 for the same prior year periods;
  • Total revenues of $1.26 billion for the three months ended September 30, 2009;
  • Total revenues of $3.74 billion for the nine months ended September 30, 2009;
  • On a GAAP basis, a loss per diluted share of $0.13 for the three months ended September 30, 2009;
  • On a GAAP basis, earnings per diluted share of $0.29 for the nine months ended September 30, 2009.

Mylan's Chairman and CEO Robert J. Coury commented: "I am particularly pleased with these results in light of the fact that they were achieved through higher volumes, market growth, and multiple new product launches across the globe and not from any one product. This is clearly indicative of the efficient, globally diverse business model that we've created and is reflective of our operators' continued exemplary execution that has led to the accelerated realization of our integration-related synergies."

Coury continued: "We are increasing the range of our full year 2009 adjusted diluted EPS guidance to $1.24 - $1.28, and we are confident that this momentum will continue into 2010 and enable us to once again deliver the revenue and earnings performance growth that we envision."

SOURCE Mylan Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.